Background: Inadequate description of palliative care cancer patients in research studies often leads to results having limited generalizability. To standardize the description of the sample, the European Association for Palliative Care basic data set was developed, with 31 core demographic and disease-related variables. Aim: To pilot test the data set to check acceptability, comprehensibility and feasibility. Design: International, multi-centre pilot study at nine study sites in five European countries, using mixed methods. Setting/participants: Adult cancer patients and staff in palliative care units, hospices and home care. Results: In all, 191 patients (544 screened) and 190 health care personnel were included. Median time to fill in the patient form was 5 min and the health care personnel form was 7 min. Ethnicity was the most challenging item for patients and requires decisions at a national level about whether or how to include. Health care personnel found weight loss, principal diagnosis, additional diagnoses and stage of non-cancer diseases most difficult to respond to. Registration of diagnoses will be changed from International Statistical Classification of Diseases and Related Health Problems, 10th version code to a predefined list, while weight loss and stage of noncancer diseases will be removed. The pilot study has led to rewording of items, improvement in response options and shortening of the data set to 29 items. Conclusion: Pilot testing of the first version of the European Association for Palliative Care basic data set confirmed that patients and health care personnel understand the questions in a consistent manner and can answer within an acceptable timeframe. The pilot testing has led to improvement, and the new version is now subject to further testing.
What is already known about the topic?
• • There is a need to standardize the description of a palliative care cancer patient population.
• • The European Association for Palliative Care (EAPC) basic data set has been developed to standardize research reporting. • • The data set is a combination of patient-reported outcome measures (PROMs) and disease-related variables recorded by health care personnel.
What this paper adds?
• • The first version of the EAPC basic data set has been quality assured through thorough and systematic pre-testing in the two target groups, patients and health care personnel, across five European countries. • • Pilot testing has led to a shortened data set with better clarity and more suitable response options.
Implication for practice, theory or policy
• • The resulting EAPC basic data set is an international, consensus-based, quality-assured tool that may increase external validity of research results. Further testing will make this tool a more robust standardized research reporting data set.
Introduction
Are these findings relevant for my own patients? This is a question all clinicians should ask after having read a report on a clinical study within their field. Palliative care is no exception, and palliative care populations are even more heterogeneous than in many other areas of medicine. Within the palliative care cancer population, differences in patient characteristics such as cancer diagnosis, disease status, symptoms, physical functioning, cancer-directed treatment and estimated survival, as well as differences in the organization and delivery of services, are a major concern when considering both applicability and generalizability of research findings. [1] [2] [3] [4] [5] These challenges call for uniform standards on how to describe the population and the setting of the study. Four literature reviews have examined how palliative care populations were described in research reports. [6] [7] [8] [9] All four concluded that the populations were inconsistently and insufficiently described. The authors highlighted the need for a set of common descriptors to be used when reporting sample characteristics, a need also acknowledged in several other publications. [10] [11] [12] [13] [14] As a response to this, the European Palliative Care Research Centre (PRC) 15 in collaboration with the European Association for Palliative Care Research Network (EAPC-RN) 16 and the EU-funded PRISMA project 17 launched a project to develop and reach consensus on a basic set of variables to describe a palliative care cancer population. Through an international Delphi process of five rounds, consensus was reached on a set of 31 core variables (the first version of the European Association for Palliative Care (EAPC) basic data set) to be used to describe a palliative care cancer population in research and on how the variables should be measured and recorded 18 ( Figure 1 ).
The aim of this study was to pilot test the first version of the EAPC basic data set in palliative care cancer patients and health care personnel to assess its acceptability, comprehensibility and feasibility, and to use this information to adapt the data set if needed.
Methods

Study design and setting
This was an international multi-centre study using pretesting survey procedures combining quantitative and qualitative methods, 19, 20 conducted at the following sites: The centres were recruited through an open invitation presented at palliative care conferences, and from established collaborative research networks. Each centre contributed a minimum of 15 patients to the study.
In each country, an experienced researcher (M.F., M.I.B., M.C., R.M. or K.R.S.) was responsible for recruiting local study coordinators/interviewers. The local study coordinators had different professional backgrounds (registered nurse, research nurse, physician or medical student), research credentials and research experience. Data were collected in the period September 2015-December 2016.
Translation
The first version of the EAPC basic data set was developed in English. Translation into the native language was performed in France, Norway and Italy. The national study coordinators (M.F., M.C. and K.R.S.) were responsible for the translations. In France, the translation was carried out according to the European Organization for Research and Treatment of Cancer (EORTC) procedure. 21 In Norway and Italy, the translation process involved one forward translation from English into the target language by a translator with medical background, good command of English and the target language as his or her native language. The translated version of the data set was then checked by two independent persons fluent in the target language and with good knowledge of English, and consensus was reached in case of incongruence. Following the translation, the data set was completed by a small sample of the target population to check comprehensibility.
Two other documents were translated in the same way: 'Pilot testing the EAPC basic data set: structured interview guide' and 'Guidelines for using the EAPC basic data set'.
The qualitative data were translated into English by one of the local study coordinators in France. In Italy, data were translated by one physician and reviewed by another. Qualitative data from participants in Norway were analysed without being translated.
Participants
Participants for the pilot testing were as follows:
1. Patients admitted to palliative care services as described above. Patients were eligible for the study if they had incurable cancer, age ⩾18 years and the ability to give informed consent. Patients who fulfilled the inclusion criteria but did not speak the language in question were excluded. Seven of the nine participating study centres screened potential participants. The remaining two centres recruited per convenience. 2. The patient's responsible health care provider (physician and/or nurse).
Study measures
With the aim to assess acceptability, comprehensibility and feasibility of the EAPC basic data set, the following information was collected:
1. Non-participating patients.
Age group, gender, diagnostic group and the Australiamodified Karnofsky Performance Scale (AKPS) 22 score were recorded for all non-participating patients. The reason for not participating was noted, using predefined categories.
Participants.
After the included patients had read and signed the consent form, they were asked to complete the EAPC basic data set patient form. The responsible health care provider (physician and/or nurse) was asked to complete the health care personnel form. The forms were completed on paper, followed by a standard structured interview for both respondent groups, with the questions indicated below. By the end of the interview, the participants were asked about the layout of the form, if any items were irrelevant, if the sequence of items was appropriate and if they had any other comments about the questionnaire. Only one study entry per patient was allowed. Information about the health care provider's age, gender, profession and years working in palliative care was recorded. Acceptability was assessed by asking the participants if they found any question annoying, confusing, upsetting, had comments re acceptability or found the response options unsuitable. Poor acceptability for an item was judged if >10% of participants answered positively to these questions, which is a commonly used cut-off in survey pre-testing. 20 Comprehensibility was determined insufficient if at least 10% of participants found any question difficult to respond to, if the answer was obviously incorrect or missing, or if they commented on a poorly understandable question or response option.
Feasibility was judged by how long it took the participants to complete the questionnaire, if assistance was needed and whether the requested information was readily available for the health care professionals. The ratio included/non-participating was also measured.
Data analysis
Data were entered into an online database. Analysis was by mixed methods -quantitative data were analysed using descriptive statistics, and qualitative data by the first author (K.R.S.) using content analysis. 23 The researcher read all the comments for each item many times before dividing the text into meaning units. The next step was to develop codes as descriptive labels for the meaning units, before sorting the codes into categories. Afterwards, the categories were assorted into three groups: comments on difficulties, proposals on how to improve the data set, and other comments.
Based on the analysis, decisions to change, add, delete or reword items were made by two of the authors (K.R.S. and D.F.H.). We have followed the consolidated criteria for reporting qualitative research (COREQ) checklist. 24 
Results
Screening
A total of 544 patients were screened; 353 did not participate or were excluded. Two study sites did not screen and recruited per convenience -one did not have access to interviewer on a daily basis and the other was a home care service. Table 1 presents recruitment, characteristics of the non-participating patients and the reasons for not participating. The most common reasons given were 'too unwell' (26%), 'not advanced cancer' (18%) and 'unable to give informed consent' (13%). There were great differences in the ratio included/non-participating, ranging from 0.2 to 2.6 between centres.
Pilot testing
Included patients
Altogether, 191 patients participated (Table 1) .
Patient characteristics. The patients' mean age was 67.6 years, median 69 (range: 25-90 years). Sixty-five percent were ⩾65 years old. The most common cancer group for included patients (n = 172) was cancer in digestive organs (International Statistical Classification of Diseases and Related Health Problems, 10th version (ICD-10) codes C15-26), 24%; followed by breast (C50), 15%; respiratory and intrathoracic (C30-39), 14%; male genital organs (C60-63), 13%; lymphoid and haematological malignancies (C81-96), 9%; 79% had metastatic/disseminated disease, and 36% were not receiving anticancer therapy. Seventyfive percent had performance status ⩾60. Further details are given in Tables 2 and 3 .
Patient responses. Median time to fill in the patient form was 5 min (range: 1-60 min). One hundred and twentyeight patients completed the form without assistance. Fifty-five patients required assistance; of these, 46 received assistance from health care providers, seven from a family caregiver or friend and two from a family caregiver/friend and health care provider. In five cases, the form was filled in by health care providers alone, and in two cases by a family caregiver or friend. Table 2 shows the number of responses for each variable in the patient part of the data set and missing data for each item. The most challenging variable for patients was ethnicity. The question 'What is your ethnicity?' was answered by 127 patients (66%), out of whom 108 stated their nationalities. In total, 32 patients found the question difficult to respond to; 11 found the question annoying, confusing or upsetting; and 37 gave other comments ( Figure 2 ) -the most common being 'don't understand the word ethnicity'. Figure 2 shows the participants' responses to the standardized questions asked by the interviewers, and (24) , time issues (lack of time, patient had left before researcher had time) (12) , mental health issues (5), speech difficulties (4), does not speak the language (3), hearing impairment (2), patient too tired/fatigued (4) and diverse (10). findings, ethnicity will be replaced with an open question about nationality in some countries, others will find a predefined list appropriate, while yet others will have to exclude this variable. Many patients had the same comments for more than one symptom ( Table 2) . One of the remarks was the order of symptoms on the form. Both patients and health care providers recommended grouping related symptoms together.
Age and gender were the only variables without any form of modifications. Living situation and highest completed level of education have been modified as shown in Table 2 .
Health care professionals
Health care professional characteristics. In total, 190 health care professionals gave information about themselves: mean age was 42.7 years, 165 were female professionals, 103 were physicians and 84 were nurses. The median working time within palliative care was 6 years (range: 0-40). Some of the health care professionals probably filled in more than one form.
Health care professional responses. Median time to fill in the health care personnel form was 7 min (range: 2-195). Sixteen health care professionals needed assistance to complete the health care personnel form, most commonly nurses needing information from physicians about ICD-10 codes, medications, performance status or cognitive functioning.
Eight variables were perceived as challenging in the health care personnel part, as based on questions about responding difficulties, completion, missing data and comments: principal diagnosis, date of the principal diagnosis, stage of the cancer disease, additional diagnoses, stage of the non-cancer disease, weight loss, place of care and performance status. Figure 2 shows the participants' responses to the standardized questions asked by the interviewers, and Table 3 sums up the comments:
• • The principal and additional diagnoses.
The health care personnel were supposed to fill in the principal diagnosis using an ICD-10 code. ICD-10 codes were used in 59% of cases, and type of cancer using free text in 24%. The cancer diagnosis was missing in 11%, while 6% used various other codes. Eighty-seven participants found the item difficult to respond to -the most common reason was, 'don't know the ICD-10 code' (Table 3) . One recommendation for improvement was to make a standardized list of cancer diagnoses. As a result, ICD-10 codes will be replaced by a standardized list based on ICD chapters and blocks (Table 3) . Some of the same challenges applied to the additional diagnoses. ICD-10 codes were used in 83 cases (46 were non-cancer diagnoses, 29 were cancer or metastases and 8 ICD-10 Z or R codes). The disease was written as text in 25 cases. The result will be to replace the ICD-10 code by a standardized list (Table 3 ).
• • Stage of the non-cancer disease.
Fifty-five patients were distributed between the following categories: New York Heart Association (NYHA) Functional Classification classes I (19), II (2), III (3) and IV (1); Global Initiative for Chronic Obstructive Lung Disease (GOLD) stages 1 (10), 2 (4), 3 (1) and 4 (4); and Functional Assessment Staging (FAST) scale, stages 1 (10) and 2 (1). The response distributions with dominance of the first stages caused suspicion about incorrect answers. Sixty-four health care professionals reported difficulties completing this item, and the most common comment was 'don't know the classification systems' (Table 3) . Several participants proposed to exclude this variable, or make it optional. This has resulted in removal of the variable.
• • Date of the principal diagnosis.
Date of the principal diagnosis was reported as intended in 138 cases (72%) with month and year, 46 with only year and 7 missing. Thirty-nine found the item difficult to respond to, and the most common reason was 'hard to find'. No proposals for change were received. The variable will remain unchanged.
• • Weight loss.
Only 38 participants (20%) filled in weight loss in percentage and duration of weight loss in months. This item was clearly the most difficult one to respond to (Figure 2 ). Comments are given in Table 3 . As a consequence, the variable has been removed.
• • Performance status.
Sixteen percent of the participants found the question difficult to respond to. The most common comment was 'challenging to choose the right category', and only 59% found the response options suitable. Three times two categories were marked. However, there were only 2% missing data. The AKPS is a validated tool, and in this first version of the data set, it was decided not to change the response options.
Date of the principal diagnosis and performance status were the only variables without any form of modification. The rest of the variables have been modified as shown in Table 3 .
The layout of the forms was suitable for the majority; however, there were a few comments that it was hard to read the black numbers and text on the dark green background. The green colour will consequently be changed to a brighter one.
Discussion
The first version of the EAPC basic data set has been pilot tested by altogether 381 individuals from the target groups, in five different European countries. Our results show that palliative care cancer patients and health care professionals are willing and able to use the data set. The majority of study participants reported to understand the instructions and questions. The following five variables were perceived as most challenging: ethnicity, principal diagnosis, additional diagnoses, stage of the non-cancer disease and weight loss. Consequently, the pilot testing has led to changes in the first official version of the data set.
Feasibility
Median time to fill in the form was 7 min for health care personnel and 5 min for patients, and 67% of the patients filled in the form alone. The acceptable time expenditure and the fact that two-thirds of the patients completed the form without assistance support the feasibility of the data set. However, many palliative care cancer patients were unable to participate, as only 191 out of 544 were included, with an inclusion rate of 44% for the sites that performed screening. The most common reason for not participating was being too unwell, confirming that many palliative care cancer patients are frail. The non-participants were slightly older and had a lower mean AKPS score than the participants; 53% of the non-participants had AKPS score ⩽50, compared to 24% of the included patients. However, we believe it is also possible to use the EAPC basic data set for some of these patients. The patient part can be completed by a caregiver, and rating of symptoms based either on input from the patient or by observer assessment as recommended in the guidelines for using the Edmonton Symptom Assessment SystemRevised (ESAS-r). 25 Further testing is required to test our assumption.
Probably, more patients could have been able to complete the data set and participate in the pilot. Stone et al. 26 found that gate keeping by clinical staff in palliative care research was the second most common reason for inaccessibility, with 24% of eligible patients not available for the research team. Inaccessibility or unavailability of researcher and eligible patients is also an issue. In our material, 17% of the cases not participating were due to this mismatch. One can also speculate that the need for interview after completion has been a limitation and that, in reality, there are more patients able to complete the data set.
Acceptability
There were very few negative comments regarding acceptability, and few patients reported finding questions annoying, confusing or upsetting. The wellbeing item was the one with most patients (10%) reporting 'annoying, confusing or upsetting'. The majority found the word and the scale confusing, with best wellbeing as 0 and worst wellbeing as 10. Only one patient reported to be upset. No change was made, based on the finding that 96% were able to respond to the item; another reason is that the item comes from ESAS-r. ESAS has evolved over the last 27 years and is a robust symptom assessment instrument used both in research and clinical practice. 27 We conclude that both patients and health care providers find the EAPC basic data set acceptable for use.
Comprehensibility
The participants understood the majority of the questions. The frequency of missing answers corresponded to the responses that the participants found the item difficult to respond to; however, the comments demonstrated that this was not due to finding the questions difficult to understand. The main reasons were that information was not available in the patient records, for example, concerning weight, or the respondents did not know or use the ICD-10 system. Ethnicity was the item most patients found difficult to understand.
Changes in the EAPC basic data set
The fact that this pilot study had almost 400 participants gives reason to believe that the resulting changes are well founded and will give a better version of the data set. Five variables were found to be most challenging. Two of these, ethnicity and weight loss, were variables on which consensus on method of assessment was not achieved in the Delphi process. For the purpose of the pilot testing, the research group based their choice of assessment method on comments from the Delphi panel. 18 However, the pilot testing showed that ethnicity is a tricky variable, requiring decisions at a national level about whether or how to include this item. For instance, France has a law prohibiting individuals being enumerated by ethnicity without their consent or a state committee waiver.
The use of ICD-10 for principal and additional diagnoses was also problematic. To improve the next version, individual coding will be exchanged with a standardized list based on the ICD structure. This may be more sensible as researchers are accustomed to reporting diseases in wider categories. Hopefully, clinicians will also find this solution more agreeable and less time-consuming.
The pilot testing also resulted in some adjustments in response options, both by adding new categories and by giving the option to specify in free text when answering 'other'. Relevant symptoms in the patient form have been grouped together, based on feedback from both patients and health care providers.
Strength and limitations
All nine study sites had interviewers without any connection to the development of the EAPC basic data set. Using a standardized interview guide, we tried to minimize interviewer bias.
Our study has some limitations. The fact that the translation was not performed according to the EORTC translation guidelines 21 in two countries may represent a problem. The reason for deviating from these guidelines was that many of the variables within the data set, and especially the patient-reported outcome measures (PROMs), originate from internationally established and validated tools and manuals such as the ESAS-r, 28 the AKPS and the ICD-10, 29 and were taken from authorized translations. The additional items concern objective information only.
Screening was not performed at all the participating centres. There were big differences in the ratio of included versus not participating among the study sites, an observation which cannot be explained by differences in average age or mean AKPS at the different sites. The reasons are probably multi-factorial, relating to all the three main 'bottlenecks' to recruitment to a multi-centre palliative care study -eligibility, accessibility and consent, as identified by Stone et al. 26 The two centres with the highest numbers of non-participating patients were hospices with the most beds. However, there were differences in the case mix between the centres. One of the centres with the lowest ratio had 20% non-cancer patients in the population, while the centre with the highest ratio only served cancer patients. Unavailability of the researcher or patient was also more common at the sites with high numbers of non-participating patients. The researcher's personal traits, the way patients were informed and invited to participate, and the personal interaction between the researcher and clinicians have probably also affected inclusion rates. For instance, the recruitment rate improved at one site after the researcher recognized the high rate of poor literacy and offered to read the information to the patients.
Health care personnel were not supposed to participate in the study more than once. Unfortunately, this was insufficiently addressed in the study protocol. The results indicate that some professionals participated more than once, but as this deviation only concerned one of the nine study sites, we consider it of minor influence.
Despite the above-mentioned limitations, the pilot testing has given results leading to rewording, improvements in response options and removal of items from the data set. We strongly encourage researchers to use the data set as part of the case report form for studies in cancer palliative care, realizing, however, that supplementary modules may be needed for specific purposes. Using the data set in research reporting will lead to a thorough description of the study sample, which is a prerequisite for judging the external validity of the study results. 30 Further work will be needed to test the revised version of the data set. The EAPC basic data set is available at https://oslo-universitetssykehus.no/avdelinger/kreftklinikken/avdeling-for-kreftbehandling/prc-research-results#eapc-basic-dataset.
Conclusion
The first version of the EAPC basic data set has undergone pilot testing, confirming that patients and health care personnel understand the questions in a consistent manner. The pilot testing has led to rewording, changes in response options and shortening of the data set, which is now ready for use and further testing.
